These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution. Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240 [TBL] [Abstract][Full Text] [Related]
6. Biomaterial-assisted drug delivery for interstitial cystitis/bladder pain syndrome treatment. Lin Z; Hu H; Liu B; Chen Y; Tao Y; Zhou X; Li M J Mater Chem B; 2021 Jan; 9(1):23-34. PubMed ID: 33179709 [TBL] [Abstract][Full Text] [Related]
7. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment. Jiang YH; Jhang JF; Lee YK; Kuo HC Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203604 [TBL] [Abstract][Full Text] [Related]
8. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review. Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774 [TBL] [Abstract][Full Text] [Related]
9. Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat. Fraser MO; Chuang YC; Tyagi P; Yokoyama T; Yoshimura N; Huang L; De Groat WC; Chancellor MB Urology; 2003 Mar; 61(3):656-63. PubMed ID: 12639679 [TBL] [Abstract][Full Text] [Related]
10. Identification of key genes in human urothelial cells corresponding to interstitial cystitis/bladder pain syndrome in a lipopolysaccharide-induced cystitis model. Peng L; Li BY; Wang W; Gao XS; Zeng X; Luo DY Neurourol Urodyn; 2021 Sep; 40(7):1720-1729. PubMed ID: 34245600 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. Shie JH; Liu HT; Wang YS; Kuo HC BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596 [TBL] [Abstract][Full Text] [Related]
12. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study. Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S; Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency. Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287 [TBL] [Abstract][Full Text] [Related]
14. Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study. Mishra NN; Riedl C; Shah S; Pathak N Int J Urol; 2019 Jun; 26 Suppl 1():68-72. PubMed ID: 31144739 [TBL] [Abstract][Full Text] [Related]
15. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections. Dellis A; Papatsoris AG Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738 [TBL] [Abstract][Full Text] [Related]
16. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma. Lee YK; Jiang YH; Jhang JF; Ho HC; Kuo HC Biomedicines; 2022 May; 10(5):. PubMed ID: 35625918 [TBL] [Abstract][Full Text] [Related]
17. Intravesical liposome therapy for interstitial cystitis. Tyagi P; Kashyap M; Majima T; Kawamorita N; Yoshizawa T; Yoshimura N Int J Urol; 2017 Apr; 24(4):262-271. PubMed ID: 28258657 [TBL] [Abstract][Full Text] [Related]
18. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Lee CL; Kuo HC Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677 [TBL] [Abstract][Full Text] [Related]
19. Intravesical drug delivery for dysfunctional bladder. Hsu CC; Chuang YC; Chancellor MB Int J Urol; 2013 Jun; 20(6):552-62. PubMed ID: 23336527 [TBL] [Abstract][Full Text] [Related]
20. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery. GuhaSarkar S; More P; Banerjee R J Control Release; 2017 Jan; 245():147-156. PubMed ID: 27913307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]